Literature DB >> 35018535

Indolicidin revisited: biological activity, potential applications and perspectives of an antimicrobial peptide not yet fully explored.

Jaqueline Batista Araujo1, Guilherme Sastre de Souza2, Esteban Nicolas Lorenzon3.   

Abstract

The emergence of multidrug-resistant bacteria, viruses and tumors is a serious threat to public health. Among natural peptides, indolicidin, a 13-residue peptide belonging to the cathelicidin family, deserves special attention. Indolicidin has a broad spectrum of biological activity and is active against a wide range of targets, such as bacteria (Gram+  and Gram-), fungi and viruses. Here, we review the most important features of the biological activity, potential applications and perspectives of indolicidin and its analogs. Although not yet approved for commercialization, this peptide has great potential to be applied in different areas, including the medical, biomedical, food industry and other unexplored areas. To achieve this goal, a multidisciplinary team of researchers must work together to fine tune peptides that overall lead to novel analogs and formulations to combat existing and possibly future diseases.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Antimicrobial activity; Indolicidin; Indolicidin analogs

Mesh:

Substances:

Year:  2022        PMID: 35018535     DOI: 10.1007/s11274-022-03227-2

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  65 in total

1.  Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts.

Authors:  Monica Benincasa; Marco Scocchi; Sabrina Pacor; Alessandro Tossi; Donatella Nobili; Giancarlo Basaglia; Marina Busetti; Renato Gennaro
Journal:  J Antimicrob Chemother       Date:  2006-10-05       Impact factor: 5.790

2.  In vitro pharmacokinetics of antimicrobial cationic peptides alone and in combination with antibiotics against methicillin resistant Staphylococcus aureus biofilms.

Authors:  Sibel Dosler; Emel Mataraci
Journal:  Peptides       Date:  2013-08-26       Impact factor: 3.750

3.  Probing the role of Proline in the antimicrobial activity and lipopolysaccharide binding of indolicidin.

Authors:  Swapna Bera; Anirban Ghosh; Shruti Sharma; Tanmoy Debnath; Banabihari Giri; Anirban Bhunia
Journal:  J Colloid Interface Sci       Date:  2015-04-25       Impact factor: 8.128

Review 4.  Bacterial resistance to antimicrobial peptides.

Authors:  Milad Abdi; Shiva Mirkalantari; Nour Amirmozafari
Journal:  J Pept Sci       Date:  2019-10-21       Impact factor: 1.905

5.  Antiviral activity of antimicrobial cationic peptides against Junin virus and herpes simplex virus.

Authors:  Vanesa C Albiol Matanic; Viviana Castilla
Journal:  Int J Antimicrob Agents       Date:  2004-04       Impact factor: 5.283

Review 6.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

7.  In-vitro activity of lytic peptides alone and in combination with macrolides and inhibitors of dihydrofolate reductase against Pneumocystis carinii.

Authors:  O Cirioni; A Giacometti; F Barchiesi; G Scalise
Journal:  J Antimicrob Chemother       Date:  1998-10       Impact factor: 5.790

Review 8.  Antimicrobial peptides with selective antitumor mechanisms: prospect for anticancer applications.

Authors:  Berthony Deslouches; Y Peter Di
Journal:  Oncotarget       Date:  2017-07-11

Review 9.  Immunomodulatory properties of defensins and cathelicidins.

Authors:  D M E Bowdish; D J Davidson; R E W Hancock
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

10.  Efficiency of gold nanoparticles coated with the antimicrobial peptide indolicidin against biofilm formation and development of Candida spp. clinical isolates.

Authors:  Elisabetta de Alteriis; Valeria Maselli; Annarita Falanga; Stefania Galdiero; Federica Maria Di Lella; Renato Gesuele; Marco Guida; Emilia Galdiero
Journal:  Infect Drug Resist       Date:  2018-07-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.